Literature DB >> 32174128

Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China.

Zenghui Cheng1, Yong Lu1, Qiqi Cao1, Le Qin1, Zilai Pan1, Fuhua Yan1, Wenjie Yang1.   

Abstract

OBJECTIVE. Confronting the new coronavirus infection known as coronavirus disease 2019 (COVID-19) is challenging and requires excluding patients with suspected COVID-19 who actually have other diseases. The purpose of this study was to assess the clinical features and CT manifestations of COVID-19 by comparing patients with COVID-19 pneumonia with patients with non-COVID-19 pneumonia who presented at a fever observation department in Shanghai, China. MATERIALS AND METHODS. Patients were retrospectively enrolled in the study from January 19 through February 6, 2020. All patients underwent real-time reverse transcription-polymerase chain reaction (RT-PCR) testing. RESULTS. Eleven patients had RT-PCR test results that were positive for severe acute respiratory syndrome coronavirus 2, whereas 22 patients had negative results. No statistical difference in clinical features was observed (p > 0.05), with the exception of leukocyte and platelet counts (p < 0.05). The mean (± SD) interval between onset of symptoms and admission to the fever observation department was 4.40 ± 2.00 and 5.52 ± 4.00 days for patients with positive and negative RT-PCR test results, respectively. The frequency of opacifications in patients with positive results and patients with negative results, respectively, was as follows: ground-glass opacities (GGOs), 100.0% versus 90.9%; mixed GGO, 63.6% versus 72.7%; and consolidation, 54.5% versus 77.3%. In patients with positive RT-PCR results, GGOs were the most commonly observed opacification (seen in 100.0% of patients) and were predominantly located in the peripheral zone (100.0% of patients), compared with patients with negative results (31.8%) (p = 0.05). The median number of affected lung lobes and segments was higher in patients with positive RT-PCR results than in those with negative RT-PCR results (five vs 3.5 affected lobes and 15 vs nine affected segments; p < 0.05). Although the air bronchogram reticular pattern was more frequently seen in patients with positive results, centrilobular nodules were less frequently seen in patients with positive results. CONCLUSION. At the point during the COVID-19 outbreak when this study was performed, imaging patterns of multifocal, peripheral, pure GGO, mixed GGO, or consolidation with slight predominance in the lower lung and findings of more extensive GGO than consolidation on chest CT scans obtained during the first week of illness were considered findings highly suspicious of COVID-19.

Entities:  

Keywords:  COVID-19; CT; coronavirus disease 2019; pneumonia

Mesh:

Year:  2020        PMID: 32174128     DOI: 10.2214/AJR.20.22959

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  108 in total

1.  Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-Analysis.

Authors:  Ashish Kumar; Anil Arora; Praveen Sharma; Shrihari Anil Anikhindi; Naresh Bansal; Vikas Singla; Shivam Khare; Abhishyant Srivastava
Journal:  SSRN       Date:  2020-04-21

Review 2.  The role of chest computed tomography in the management of COVID-19: A review of results and recommendations.

Authors:  Molly D Wong; Theresa Thai; Yuhua Li; Hong Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-26

3.  COVID-19 pneumonia: microvascular disease revealed on pulmonary dual-energy computed tomography angiography.

Authors:  Franck Grillet; Andreas Busse-Coté; Paul Calame; Julien Behr; Eric Delabrousse; Sébastien Aubry
Journal:  Quant Imaging Med Surg       Date:  2020-09

4.  A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.

Authors:  Taha Yusuf Kuzan; Kübra Murzoğlu Altıntoprak; Hatice Özge Çiftçi; Umut Ergül; Nur Betül Ünal Özdemir; Muhammet Bulut; Nurettin Yiyit
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

Review 5.  A systematic review of chest imaging findings in COVID-19.

Authors:  Zhonghua Sun; Nan Zhang; Yu Li; Xunhua Xu
Journal:  Quant Imaging Med Surg       Date:  2020-05

6.  Learning from pathophysiological aspects of COVID-19 clinical, laboratory, and high-resolution CT features: a retrospective analysis of 128 cases by disease severity.

Authors:  Sameh Mostafa Azab; Ashraf Anas Zytoon; Zeinab Abdel Aziz Kasemy; Suzan Fouad Omar; Suzy Fayez Ewida; Karim Ayman Sakr; Tarek Fawzy Abd Ella
Journal:  Emerg Radiol       Date:  2021-01-08

7.  Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy.

Authors:  Andrea Bianco; Tullio Valente; Fabio Perrotta; Elvira Stellato; Luca Brunese; Brad J Wood; Gianpaolo Carrafiello; Roberto Parrella
Journal:  Heliyon       Date:  2021-05-20

8.  Thoracic imaging tests for the diagnosis of COVID-19.

Authors:  Nayaar Islam; Sanam Ebrahimzadeh; Jean-Paul Salameh; Sakib Kazi; Nicholas Fabiano; Lee Treanor; Marissa Absi; Zachary Hallgrimson; Mariska Mg Leeflang; Lotty Hooft; Christian B van der Pol; Ross Prager; Samanjit S Hare; Carole Dennie; René Spijker; Jonathan J Deeks; Jacqueline Dinnes; Kevin Jenniskens; Daniël A Korevaar; Jérémie F Cohen; Ann Van den Bruel; Yemisi Takwoingi; Janneke van de Wijgert; Johanna Aag Damen; Junfeng Wang; Matthew Df McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-03-16

Review 9.  Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis.

Authors:  Suchismita Panda; Rachita Nanda; Prasanta Kumar Tripathy; Manaswini Mangaraj
Journal:  J Family Med Prim Care       Date:  2021-04-08

Review 10.  Chest computed tomography as a primary tool in COVID-19 detection: an update meta-analysis.

Authors:  Caishuang Pang; Qingtao Hou; Zhaowei Yang; Liwei Ren
Journal:  Clin Transl Imaging       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.